Advancing Precision Dementia Care With Genetic-Exposome Risk Assessment

JAMA Neurology 2026

View at publisher
Authors: Shea J. Andrews, Kristine Yaffe
DOI: 10.1001/jamaneurol.2026.0573
Cited by: 2
References: 9

Abstract

This Viewpoint advocates for an integrated genetic-exposome risk assessment framework for early identification and targeted treatment of Alzheimer disease.

Fields of Study & Subjects

Health Environment Cognitive Aging Nutrition Genetics and Disease Metabolomics and Mass Spectrometry Studies

Publication details

Journal / source
JAMA Neurology
Publisher
American Medical Association (AMA)
Volume
83
Issue
6
Pages
513–513
Publication date
6 April 2026
Language
EN